A Study of DS-1001b in Patients With Chemotherapy- and Radiotherapy-Naive IDH1 Mutated WHO Grade II Glioma
A Study of DS-1001b in Patients With Chemotherapy- and Radiotherapy-Naive IDH1 Mutated WHO Grade II Glioma
Active, not recruiting · NCT04458272 · Registry updated 2026-10-06Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A Study of DS-1001b in Patients With Chemotherapy- and Radiotherapy-Naive IDH1 Mutated WHO Grade II Glioma | Neoplasms by Histologic Type, Neoplasms, Germ Cell and Embryonal, Neoplasms, Nerve Tissue, epithelial neoplasm, glioma, grade II glioma, neoplasm, neuroepithelial neoplasm, primitive neuroectodermal tumor | Active, not recruiting | Phase 2 | 2026-10-06 | NCT04458272 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Daiichi Sankyo Co., Ltd. | 14 |
11 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Hiroshima University Hospital | Hiroshima | Japan | 13 |
| Kitasato University Hospital | Sagamihara | Japan | 6 |
| Kumamoto University Hospital | Kumamoto | Japan | 8 |
| Kyorin University Hospital | Tokyo | Japan | 3 |
| Kyoto University Hospital | Kyoto | Japan | 15 |
| Nagoya University Hospital | Nagoya | Japan | 9 |
| National Cancer Center Hospital | Tokyo | Japan | 20 |
| National Hospital Organization Osaka National Hospital | Osaka | Japan | 5 |
| Saitama Medical University International Medical Center | Hidaka | Japan | 8 |
| Tohoku University Hospital | Sendai | Japan | 16 |
| Tokyo Women's Medical University Hospital | Tokyo | Japan | 4 |